Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is
Multiformat camera and PACS firmVisiplex Instruments last month acquired worldwide sales and marketingrights to Nuclear Data's IV 4600 film recorder, which recordsvideo images from modalities that use an ultra-high line videosignal. The acquisition is the first step in a Visiplex plan toacquire Nuclear Data's entire line of film recorders, accordingto the Elmsford, NY, company.
Visiplex intends to dominate the field of multiformat camerasas long as the technology is available and plans to increase itsmarket share through acquisition, according to Seamus Carroll,vice president of sales and marketing. Visiplex moved into PACSwith the acquisition of Genesys earlier this year (SCAN 8/10/94).
At the RSNA meeting, Visiplex displayed MRI Read Station, a three-monitorconfiguration of Imlogix displays developed for MRI studies. Visiplexalso displayed a new Windows-based version of the FilmFax productformerly marketed by Genesys.
Can Innovations with AI Help Address the Impact of Staffing Shortages on Radiology Workflow?
October 7th 2024While staffing shortages in radiology continue to persist after the COVID-19 pandemic, current and emerging innovations powered by artificial intelligence (AI) may help facilities navigate these challenges and mitigate rising costs of health care.
CT Study Links Pleural Effusion and Higher 30-Day Mortality Rates in Patients with COVID-19
October 1st 2024In a multicenter study of over 1,100 patients with COVID-19, pleural effusion was detected on CT scans in nearly a third of patients, who also had significantly higher ICU admission and 30-day mortality rates.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.